ArticleMolecular and cellular biochemistry2026
The adaptor protein ARAP contributes to Akt-dependent NF-κB p50 activation and inflammatory cytokine production in dendritic cells.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adaptor proteins play critical roles in determining the specificity of innate immune signaling pathways. Here, we report that a previously uncharacterized adaptor protein, ARAP (activation-dependent, raft-recruited ADAP-like phospho-protein), is critical for lipopolysaccharide (LPS)-induced cytokine production in dendritic cells (DCs). Bone marrow-derived DCs (BMDCs) isolated from ARAP knockout (ARAP-KO) mice exhibited a significant reduction in proinflammatory cytokine production following LPS stimulation. Mechanistically, ARAP-KO-derived BMDCs displayed normal activation of mitogen-activated protein kinases and inhibitor of κBα (IκBα) degradation, along with preserved nuclear translocation of nuclear factor-κB (NF-κB) p65. However, the nuclear translocation of the NF-κB p50 subunit was markedly impaired. Concomitantly, LPS-induced Akt phosphorylation was attenuated in ARAP-KO-derived BMDCs. Pharmacological inhibition of Akt in wild-type BMDCs phenocopied the defect in p50 nuclear translocation. These findings reveal a non-canonical mechanism in which ARAP is required for p50 nuclear translocation in an Akt-dependent pathway, independent of classical IκB kinase-IκB signaling, adding mechanistic insight into innate immune signaling.
Indexed as
Identifiers
42803870What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.